Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply.

Literature DB >> 30995384

Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply.

Stephen J Schuster¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2019 PMID： 30995384 DOI： 10.1056/NEJMc1901464

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

Authors: Enli Liu; David Marin; Pinaki Banerjee; Homer A Macapinlac; Philip Thompson; Rafet Basar; Lucila Nassif Kerbauy; Bethany Overman; Peter Thall; Mecit Kaplan; Vandana Nandivada; Indresh Kaur; Ana Nunez Cortes; Kai Cao; May Daher; Chitra Hosing; Evan N Cohen; Partow Kebriaei; Rohtesh Mehta; Sattva Neelapu; Yago Nieto; Michael Wang; William Wierda; Michael Keating; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal: N Engl J Med Date: 2020-02-06 Impact factor: 91.245

2. Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience.

Authors: Samantha J Seitter; Paul H McClelland; Mark A Ahlman; Stephanie L Goff; James C Yang; Lori McIntyre; Steven A Rosenberg; James N Kochenderfer; Jennifer N Brudno
Journal: Leuk Lymphoma Date: 2022-06-09

Review 3. Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15^th-16^th February 2019, Doha, Qatar.

Authors: Bella Guerrouahen; Muhammad Elnaggar; Anjud Al-Mohannadi; Dhanya Kizhakayil; Chiara Bonini; Reuben Benjamin; Renier Brentjens; Christian J Buchholz; Giulia Casorati; Soldano Ferrone; Frederick L Locke; Francisco Martin; Axel Schambach; Cameron Turtle; Paul Veys; Hans J van der Vliet; Cristina Maccalli
Journal: Front Immunol Date: 2021-01-14 Impact factor: 7.561

4. Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.

Authors: Elizabeth M Holland; Bonnie Yates; Alex Ling; Constance M Yuan; Hao-Wei Wang; Maryalice Stetler-Stevenson; Michael LaLoggia; John C Molina; Daniel A Lichtenstein; Daniel W Lee; John A Ligon; Haneen Shalabi; Mark A Ahlman; Nirali N Shah
Journal: Blood Adv Date: 2022-04-12

Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply.

1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

2. Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience.

Review 3. Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15^th-16^th February 2019, Doha, Qatar.

4. Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.

Review 5. Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy.

Review 6. CAR T cells: Building on the CD19 paradigm.

7. EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations.

Tisagenlecleucel in Diffuse Large B-Cell Lymphoma. Reply.

1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

2. Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience.

Review 3. Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.

4. Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.

Review 5. Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy.

Review 6. CAR T cells: Building on the CD19 paradigm.

7. EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations.

Review 3. Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15^th-16^th February 2019, Doha, Qatar.